A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia
Clinical trial NCT05225558 · TERMINATED
Trial details
- NCT number
- NCT05225558
- Sponsor
- LigaChem Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2024-02-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.